{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:41:58Z","timestamp":1790487718432,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/ijo.2015.242","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T08:40:29Z","timestamp":1448959229000},"page":"193-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Anorexia\u2013cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1\/GDF15"],"prefix":"10.1038","volume":"40","author":[{"given":"V W W","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-1574","authenticated-orcid":false,"given":"A","family":"Salis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S N","family":"Breit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"BFijo2015242_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s13539-012-0082-6","volume":"3","author":"VW Tsai","year":"2012","unstructured":"Tsai VW, Husaini Y, Manandhar R, Lee-Ng KK, Zhang HP, Harriott K et al. Anorexia\/cachexia of chronic diseases: a role for the TGF-\u03b2 family cytokine MIC-1\/GDF15. J Cachexia Sarcopenia Muscle 2012; 3: 239\u2013243.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"BFijo2015242_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.critrevonc.2010.10.004","volume":"80","author":"D Blum","year":"2011","unstructured":"Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P et al. Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 2011; 80: 114\u2013144.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFijo2015242_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ . Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014; 14: 754\u2013762.","journal-title":"Nat Rev Cancer"},{"key":"BFijo2015242_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V . Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 2013; 10: 90\u201399.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFijo2015242_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489\u2013495.","journal-title":"Lancet Oncol"},{"key":"BFijo2015242_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon KC, Glass DJ, Guttridge DC . Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 2012; 16: 153\u2013166.","journal-title":"Cell Metab"},{"key":"BFijo2015242_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MCO.0b013e32832c7ae1","volume":"12","author":"M Muscaritoli","year":"2009","unstructured":"Muscaritoli M, Molfino A, Bollea MR, Rossi Fanelli F . Malnutrition and wasting in renal disease. Curr Opin Clin Nutr Metab Care 2009; 12: 378\u2013383.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFijo2015242_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0167-5273(02)00236-X","volume":"85","author":"M Plauth","year":"2002","unstructured":"Plauth M, Sch\u00fctz ET . Cachexia in liver cirrhosis. Int J Cardiol 2002; 85: 83\u201387.","journal-title":"Int J Cardiol"},{"key":"BFijo2015242_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","volume":"121","author":"S von Haehling","year":"2009","unstructured":"von Haehling S, Lainscak M, Springer J, Anker SD . Cardiac cachexia: a systematic overview. Pharmacol Ther 2009; 121: 227\u2013252.","journal-title":"Pharmacol Ther"},{"key":"BFijo2015242_CR10","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","volume":"280","author":"S Schiaffino","year":"2013","unstructured":"Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M . Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013; 280: 4294\u20134314.","journal-title":"FEBS J"},{"key":"BFijo2015242_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/SPC.0b013e328359b681","volume":"6","author":"A Banerjee","year":"2012","unstructured":"Banerjee A, Guttridge DC . Mechanisms for maintaining muscle. Curr Opin Support Palliat Care 2012; 6: 451\u2013456.","journal-title":"Curr Opin Support Palliat Care"},{"key":"BFijo2015242_CR12","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ng.2772","volume":"45","author":"R Sartori","year":"2013","unstructured":"Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E et al. BMP signaling controls muscle mass. Nat Genet 2013; 45: 1309\u20131318.","journal-title":"Nat Genet"},{"key":"BFijo2015242_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1096\/fj.03-0610com","volume":"18","author":"SH Lecker","year":"2004","unstructured":"Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18: 39\u201351.","journal-title":"FASEB J"},{"key":"BFijo2015242_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/8756-3282(96)00162-7","volume":"19","author":"SW Kooh","year":"1996","unstructured":"Kooh SW, Noriega E, Leslie K, Muller C, Harrison JE . Bone mass and soft tissue composition in adolescents with anorexia nervosa. Bone 1996; 19: 181\u2013188.","journal-title":"Bone"},{"key":"BFijo2015242_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ajcn\/31.1.23","volume":"31","author":"M Barac-Nieto","year":"1978","unstructured":"Barac-Nieto M, Spurr GB, Lotero H, Maksud MG . Body composition in chronic undernutrition. Am J Clin Nutr 1978; 31: 23\u201340.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2015242_CR16","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 1997; 94: 11514\u201311519.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFijo2015242_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-1119(99)00309-1","volume":"237","author":"M Bottner","year":"1999","unstructured":"Bottner M, Laaff M, Schechinger B, Rappold G, Unsicker K, Suter-Crazzolara C . Characterization of the rat, mouse, and human genes of growth\/differentiation factor-15\/macrophage inhibiting cytokine-1 (GDF-15\/MIC-1). Gene 1999; 237: 105\u2013111.","journal-title":"Gene"},{"key":"BFijo2015242_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1124\/mol.59.4.901","volume":"59","author":"SJ Baek","year":"2001","unstructured":"Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling. TE . Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001; 59: 901\u2013908.","journal-title":"Mol Pharmacol"},{"key":"BFijo2015242_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jlb.65.1.2","volume":"65","author":"WD Fairlie","year":"1999","unstructured":"Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit. SN . MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol 1999; 65: 2\u20135.","journal-title":"J Leukoc Biol"},{"key":"BFijo2015242_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2144\/02331rr03","volume":"33","author":"DA Brown","year":"2002","unstructured":"Brown DA, Bauskin AR, Fairlie WD, Smith MD, Liu T, Xu N et al. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 2002; 33: 118\u2013120 122, 124 passim.","journal-title":"Biotechniques"},{"key":"BFijo2015242_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/jnci\/djh227","volume":"96","author":"F Lindmark","year":"2004","unstructured":"Lindmark F, Zheng SL, Wiklund F, Bensen J, B\u00e4lter KA, Chang B et al. H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. J Natl Cancer Inst 2004; 96: 1248\u20131254.","journal-title":"J Natl Cancer Inst"},{"key":"BFijo2015242_CR22","first-page":"2642","volume":"9","author":"DA Brown","year":"2003","unstructured":"Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003; 9: 2642\u20132650.","journal-title":"Clin Cancer Res"},{"key":"BFijo2015242_CR23","first-page":"184","volume":"17","author":"T Tanno","year":"2010","unstructured":"Tanno T, Noel P, Miller JL . Growth differentiation factor 15 in erythroid health and disease. Curr Opin Hematol 2010; 17: 184\u2013190.","journal-title":"Curr Opin Hematol"},{"key":"BFijo2015242_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/08977194.2011.607137","volume":"29","author":"SN Breit","year":"2011","unstructured":"Breit SN, Johnen H, Cook AD, Tsai VW, Mohammad MG, Kuffner T et al. The TGF-beta superfamily cytokine, MIC-1\/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 2011; 29: 187\u2013195.","journal-title":"Growth Factors"},{"key":"BFijo2015242_CR25","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","volume":"66","author":"AR Bauskin","year":"2006","unstructured":"Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M et al. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 2006; 66: 4983\u20134986.","journal-title":"Cancer Res"},{"key":"BFijo2015242_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.hfc.2009.04.006","volume":"5","author":"T Kempf","year":"2009","unstructured":"Kempf T, Wollert KC . Growth-differentiation factor-15 in heart failure. Heart Fail Clin 2009; 5: 537\u2013547.","journal-title":"Heart Fail Clin"},{"key":"BFijo2015242_CR27","doi-asserted-by":"publisher","first-page":"20127","DOI":"10.1074\/jbc.M909580199","volume":"275","author":"PX Li","year":"2000","unstructured":"Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000; 275: 20127\u201320135.","journal-title":"J Biol Chem"},{"key":"BFijo2015242_CR28","first-page":"1023","volume":"2","author":"H Yang","year":"2003","unstructured":"Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT . Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2003; 2: 1023\u20131029.","journal-title":"Mol Cancer Ther"},{"key":"BFijo2015242_CR29","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1074\/jbc.M305295200","volume":"279","author":"SJ Baek","year":"2004","unstructured":"Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE . Expression of NAG-1, a TGF-b superfamily member, by troglitazone requires the early growth response gene Egr-1. J Biol Chem 2004; 279: 6883\u20136892.","journal-title":"J Biol Chem"},{"key":"BFijo2015242_CR30","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0140-6736(02)09093-1","volume":"359","author":"DA Brown","year":"2002","unstructured":"Brown DA, Breit SN, Buring J, Fairlie WD, Bauskin AR, Liu T et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 2002; 359: 2159\u20132163.","journal-title":"Lancet"},{"key":"BFijo2015242_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/1055-9965.EPI-11-0786","volume":"21","author":"DA Brown","year":"2012","unstructured":"Brown DA, Hance KW, Rogers CJ, Sansbury LB, Albert PS, Murphy G et al. Serum macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a potential screening tool for the prevention of colon cancer? Cancer Epidemiol Biomarkers Prev 2012; 21: 337\u2013346.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFijo2015242_CR32","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2008-0952","volume":"150","author":"Q Ding","year":"2009","unstructured":"Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 2009; 150: 1688\u20131696.","journal-title":"Endocrinology"},{"key":"BFijo2015242_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/plac.2002.0881","volume":"24","author":"AB Marjono","year":"2003","unstructured":"Marjono AB, Brown DA, Horton KE, Wallace EM, Breit SN, Manuelpillai U . Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. Placenta 2003; 24: 100\u2013106.","journal-title":"Placenta"},{"key":"BFijo2015242_CR34","first-page":"4781","volume":"85","author":"AG Moore","year":"2000","unstructured":"Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML et al. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J Clin Endocrinol Metab 2000; 85: 4781\u20134788.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2015242_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0140-6736(03)15265-8","volume":"363","author":"S Tong","year":"2004","unstructured":"Tong S, Marjono B, Brown DA, Mulvey S, Breit SN, Manuelpillai U et al. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet 2004; 363: 129\u2013130.","journal-title":"Lancet"},{"key":"BFijo2015242_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","volume":"98","author":"T Kempf","year":"2006","unstructured":"Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury. Circ Res 2006; 98: 351\u2013360.","journal-title":"Circ Res"},{"key":"BFijo2015242_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/art.22410","volume":"56","author":"DA Brown","year":"2007","unstructured":"Brown DA, Moore J, Johnen H, Smeets TJ, Bauskin AR, Kuffner T et al. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis Rheum 2007; 56: 753\u2013764.","journal-title":"Arthritis Rheum"},{"key":"BFijo2015242_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ndt\/gfr575","volume":"27","author":"SN Breit","year":"2012","unstructured":"Breit SN, Carrero JJ, Tsai VW, Yagoutifam N, Luo W, Kuffner T et al. Macrophage inhibitory cytokine-1 (MIC-1\/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant 2012; 27: 70\u201375.","journal-title":"Nephrol Dial Transplant"},{"key":"BFijo2015242_CR39","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2337\/dc09-2174","volume":"33","author":"M Lajer","year":"2010","unstructured":"Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P . Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetes Care 2010; 33: 1567\u20131572.","journal-title":"Diabetes Care"},{"key":"BFijo2015242_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/EJE-09-0417","volume":"161","author":"I Dostalova","year":"2009","unstructured":"Dostalova I, Roubicek T, Bartlova M, Mraz M, Lacinova Z, Haluzikova D et al. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol 2009; 161: 397\u2013404.","journal-title":"Eur J Endocrinol"},{"key":"BFijo2015242_CR41","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/acel.12116","volume":"12","author":"T Fuchs","year":"2013","unstructured":"Fuchs T, Trollor JN, Crawford J, Brown DA, Baune BT, Samaras K et al. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline\u2014the Sydney Memory and Aging Study. Aging Cell 2013; 12: 882\u2013889.","journal-title":"Aging Cell"},{"key":"BFijo2015242_CR42","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1073\/pnas.0530278100","volume":"100","author":"JB Welsh","year":"2003","unstructured":"Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 2003; 100: 3410\u20133415.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFijo2015242_CR43","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","volume":"9","author":"FE Wiklund","year":"2010","unstructured":"Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L et al. Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality. Aging Cell 2010; 9: 1057\u20131064.","journal-title":"Aging Cell"},{"key":"BFijo2015242_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/1078-0432.CCR-05-1331","volume":"12","author":"DA Brown","year":"2006","unstructured":"Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR et al. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clin Cancer Res 2006; 12: 89\u201396.","journal-title":"Clin Cancer Res"},{"key":"BFijo2015242_CR45","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","volume":"10","author":"J Koopmann","year":"2004","unstructured":"Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004; 10: 2386\u20132392.","journal-title":"Clin Cancer Res"},{"key":"BFijo2015242_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ygyno.2010.05.032","volume":"118","author":"AC Staff","year":"2010","unstructured":"Staff AC, Bock AJ, Becker C, Kempf T, Wollert KC, Davidson B . Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer. Gynecol Oncol 2010; 118: 237\u2013243.","journal-title":"Gynecol Oncol"},{"key":"BFijo2015242_CR47","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1158\/0008-5472.CAN-04-3827","volume":"65","author":"AR Bauskin","year":"2005","unstructured":"Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M et al. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res 2005; 65: 2330\u20132336.","journal-title":"Cancer Res"},{"key":"BFijo2015242_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jir.2009.0052","volume":"30","author":"AR Bauskin","year":"2010","unstructured":"Bauskin AR, Jiang L, Luo XW, Wu L, Brown DA, Breit. SN . The TGF-beta superfamily cytokine MIC-1\/GDF15: secretory mechanisms facilitate creation of latent stromal stores. J Interferon Cytokine Res 2010; 30: 389\u2013397.","journal-title":"J Interferon Cytokine Res"},{"key":"BFijo2015242_CR49","doi-asserted-by":"publisher","first-page":"e43833","DOI":"10.1371\/journal.pone.0043833","volume":"7","author":"Y Husaini","year":"2012","unstructured":"Husaini Y, Qiu MR, Lockwood GP, Luo XW, Shang P, Kuffner T et al. Macrophage inhibitory cytokine-1 (MIC-1\/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice. PLoS One 2012; 7: e43833.","journal-title":"PLoS One"},{"key":"BFijo2015242_CR50","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1053\/j.gastro.2006.09.015","volume":"131","author":"SJ Baek","year":"2006","unstructured":"Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K et al. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 2006; 131: 1553\u20131560.","journal-title":"Gastroenterology"},{"key":"BFijo2015242_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1158\/1940-6207.CAPR-09-0057","volume":"2","author":"M Cekanova","year":"2009","unstructured":"Cekanova M, Lee SH, Donnell RL, Sukhthankar M, Eling TE, Fischer SM et al. Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer Prev Res (Phila) 2009; 2: 450\u2013458.","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFijo2015242_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00432-009-0691-4","volume":"136","author":"TA Zimmers","year":"2010","unstructured":"Zimmers TA, Gutierrez JC, Koniaris LG . Loss of GDF-15 abolishes sulindac chemoprevention in the ApcMin\/+ mouse model of intestinal cancer. J Cancer Res Clin Oncol 2010; 136: 571\u2013576.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFijo2015242_CR53","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 2007; 13: 1333\u20131340.","journal-title":"Nat Med"},{"key":"BFijo2015242_CR54","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/cncr.11178","volume":"97","author":"J Pfitzenmaier","year":"2003","unstructured":"Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace DJ, Corey E . Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 2003; 97: 1211\u20131216.","journal-title":"Cancer"},{"issue":"8 Supplement","key":"BFijo2015242_CR55","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1158\/1538-7445.AM2013-4650","volume":"73","author":"Antonio Vigano","year":"2013","unstructured":"L.L. Vigano A, Tao N, Krieger B, Feng B, Nicoletti R, Liu Q, Bai A, Weng Z, Alcindor T, Fuoco D, Gyuris J, Chiu MI . From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia. Cancer Res 2013; 73, Abstract nr 4650.","journal-title":"Cancer Research"},{"key":"BFijo2015242_CR56","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.bjc.6605532","volume":"102","author":"RJ Skipworth","year":"2010","unstructured":"Skipworth RJ, Deans DA, Tan BH, Sangster K, Paterson-Brown S, Brown DA et al. Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. Br J Cancer 2010; 102: 665\u2013672.","journal-title":"Br J Cancer"},{"key":"BFijo2015242_CR57","doi-asserted-by":"publisher","first-page":"e88553","DOI":"10.1371\/journal.pone.0088553","volume":"9","author":"Z Lu","year":"2014","unstructured":"Lu Z, Yang L, Yu J, Lu M, Zhang X, Li J et al. Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? PLoS One 2014; 9: e88553.","journal-title":"PLoS One"},{"key":"BFijo2015242_CR58","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.7314\/APJCP.2014.15.15.6047","volume":"15","author":"ZH Lu","year":"2014","unstructured":"Lu ZH, Yang L, Yu JW, Lu M, Li J, Zhou J et al. Weight loss correlates with macrophage inhibitory cytokine-1 expression and might influence outcome in patients with advanced esophageal squamous cell carcinoma. Asian Pac J Cancer Prev 2014; 15: 6047\u20136052.","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFijo2015242_CR59","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jacc.2007.04.091","volume":"50","author":"T Kempf","year":"2007","unstructured":"Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, Doehner W et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 2007; 50: 1054\u20131060.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2015242_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1743-7075-7-34","volume":"7","author":"I Dostalova","year":"2010","unstructured":"Dostalova I, Kavalkova P, Papezova H, Domluvilova D, Zikan V, Haluzik M . Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. Nutr Metab (Lond) 2010; 7: 34.","journal-title":"Nutr Metab (Lond)"},{"key":"BFijo2015242_CR61","doi-asserted-by":"publisher","first-page":"e55174","DOI":"10.1371\/journal.pone.0055174","volume":"8","author":"VW Tsai","year":"2013","unstructured":"Tsai VW, Macia L, Johnen H, Kuffner T, Manadhar R, Jorgensen SB et al. TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator. PLoS One 2013; 8: e55174.","journal-title":"PLoS One"},{"key":"BFijo2015242_CR62","doi-asserted-by":"publisher","first-page":"13640","DOI":"10.1523\/JNEUROSCI.1133-09.2009","volume":"29","author":"J Strelau","year":"2009","unstructured":"Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, Diella F et al. Progressive postnatal motoneuron loss in mice lacking GDF-15. J Neurosci 2009; 29: 13640\u201313648.","journal-title":"J Neurosci"},{"key":"BFijo2015242_CR63","doi-asserted-by":"publisher","first-page":"e34868","DOI":"10.1371\/journal.pone.0034868","volume":"7","author":"L Macia","year":"2012","unstructured":"Macia L, Tsai VW, Nguyen AD, Johnen H, Kuffner T, Shi YC et al. Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One 2012; 7: e34868.","journal-title":"PLoS One"},{"key":"BFijo2015242_CR64","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/ijo.2014.27","volume":"38","author":"K Chrysovergis","year":"2014","unstructured":"Chrysovergis K, Wang X, Kosak J, Lee SH, Kim JS, Foley JF et al. NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J Obes (Lond) 2014; 38: 1555\u20131564.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2015242_CR65","doi-asserted-by":"publisher","first-page":"690","DOI":"10.18632\/aging.100687","volume":"6","author":"X Wang","year":"2014","unstructured":"Wang X, Chrysovergis K, Kosak J, Kissling G, Streicker M, Moser G et al. hNAG-1 increases lifespan by regulating energy metabolism and insulin\/IGF-1\/mTOR signaling. Aging (Albany NY) 2014; 6: 690\u2013704.","journal-title":"Aging (Albany NY)"},{"key":"BFijo2015242_CR66","doi-asserted-by":"publisher","first-page":"e100370","DOI":"10.1371\/journal.pone.0100370","volume":"9","author":"VW Tsai","year":"2014","unstructured":"Tsai VW, Manandhar R, Jorgensen SB, Lee-Ng KK, Zhang HP, Marquis CP et al. The anorectic actions of the TGFbeta cytokine MIC-1\/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract. PLoS One 2014; 9: e100370.","journal-title":"PLoS One"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijo2015242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2015242","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2015242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T19:05:46Z","timestamp":1647371146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2015242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFijo2015242"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2015.242","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,1]]},"assertion":[{"value":"13 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Samuel Breit, David Brown and Shu Lin are inventors on patents relating to the diagnostic and\/or therapeutic applications of MIC-1\/GDF15, from which they may derive financial benefit.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}